Status:
UNKNOWN
Feasibility and Safety of Ttransendoscopic Enteral Tubing in Mid-gut
Lead Sponsor:
The Second Hospital of Nanjing Medical University
Conditions:
Transendoscopic Enteral Tubing
Eligibility:
All Genders
5-80 years
Phase:
NA
Brief Summary
A transendoscopic enteral tubing (TET ) tube was inserted into mid-gut through the nasal orifice and fixed on the pylorus wall by one tiny titanium endoscopic clip under anesthesia. This study aimed t...
Detailed Description
In recent years, fecal microbiota transplantation (FMT) has gained appeal as a therapeutic option worldwide. Traditionally, microbiota can be administered through the upper-gut, the mid-gut, and the l...
Eligibility Criteria
Inclusion
- Mild to moderate inflammatory bowel disease (Montreal classification) or suitability for endoscopy, and consented to undergo TET placement for their diseases and conditions
Exclusion
- No history of using Biologic, immunomodulatory therapy or corticosteroid therapy.
- With contraindication of endoscopy. Pregnant or lactating female
Key Trial Info
Start Date :
August 1 2015
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2017
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT03335982
Start Date
August 1 2015
End Date
December 1 2017
Last Update
December 2 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical Center for Digestive Diseases, The Second Affiliated Hospital of Nanjing Medical University
Nanjing, Jiangsu, China, 210011